Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Universite Catholique de Louvain |
| Country | Belgium |
| Start Date | Jan 01, 2025 |
| End Date | Dec 31, 2029 |
| Duration | 1,825 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 101162213 |
Antibiotic resistance is quickly becoming one of the greatest healthcare challenges of our time. It is soon expected to claim more lives annually than the COVID-19 pandemic or cancer.
Yet, the urgency of this problem is not reflected in our efforts to solve it.Because blocking bacterial growth is key in treating disease, greater insight into the bacterial cell cycle is needed. Currently, the bacterial cell cycle is primarily studied under optimal lab conditions. This is equivalent to studying the behaviour of an animal kept prisoner in a zoo.
Although valuable observations can be made, essential information will be missed.To obtain a more accurate view of bacterial growth, I will investigate the cell cycle of the major human pathogen Streptococcus pneumoniae while applying clinically relevant stresses.
Based on my first-hand experience with the S. pneumoniae cell cycle, I hypothesize that many cell cycle regulatory mechanisms have been overlooked thus far because of their relatively low importance in optimal growth conditions, which are rarely encountered in reality.I will identify genes involved in such cell cycle regulatory mechanisms at a genome-wide scale using an innovative approach I developed for this purpose.
In contrast to fitness-based nonspecific read-outs, I will perform FACS-seq (fluorescence-activated cell sorting-based sequencing) to select mutants in which specific cell cycle processes are altered based on appropriate fluorescent read-outs.
After identifying the selected mutants, I will characterize the molecular mechanisms involved and investigate their level of conservation.My research will substantially advance our understanding of how bacteria regulate their cell cycle when exposed to real-life stresses.
My results can therefore provide a starting point for the development of new antimicrobial therapies that target mechanisms important for growth in vivo. Given the emerging antibiotic resistance crisis, such efforts are urgently needed.
Universite Catholique de Louvain
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant